Latest episodesView all episodes
The increasing demand for HPAPI
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013 …Read more
A CDMO on the Covid-19 frontline
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and …Read more
Learnings from 30 years in the CDMO space
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene …Read more
The importance of positive, disruptive thinking
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens, founder at Bay Pharma. A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now …Read more
Industry insights from the people that make the headlines.
Molecule to Market takes you inside the life science outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with APIs instead of unsolved crimes and pharmaceutical personalities instead of sports stars).
About the host
Hello you. I’m Raman, the host of your favourite new podcast, Molecule to Market. After landing in the pharma sector by chance at the age of 22, I was promptly captivated by the intricacies of drug development. Today (ALMOST 20 years on), I am the proud founder of ramarketing, an international digital, design and content agency that supports companies in the industry’s outsourcing space.
As someone who rarely has the time to sit and read, I’ve learned through podcasts while travelling, exercising, and even grocery shopping. Stuck in traffic one morning listening to a Tim Ferriss podcast, I had a brainwave. “What if there was someone doing this for the pharma industry?” Lucky for you – there wasn’t. Molecule to Market was born to bring the most fascinating insights and stories from the contract services sector direct to you, wherever you may be. Enjoy!